Elevated cerebrospinal fluid glucose levels and diabetes mellitus are associated with activation of the neurotoxic polyol pathway.
Cerebrospinal fluid
Diabetes mellitus
Fructose
Hyperglycaemia
Neurocognitive function
Polyol pathway
Sorbitol
Journal
Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
15
10
2021
accepted:
17
01
2022
pubmed:
6
4
2022
medline:
10
6
2022
entrez:
5
4
2022
Statut:
ppublish
Résumé
During hyperglycaemia, some glucose bypasses glycolysis and is metabolised via the potentially neurotoxic polyol pathway, in which glucose is metabolised to sorbitol and fructose. Increased polyol concentrations have been demonstrated in the cerebrospinal fluid (CSF) of neurological patients with and without diabetes mellitus. However, polyol levels in patients without evident neurological abnormalities have not been investigated so far. The aim of this study was to determine CSF polyol concentrations in patients without major neurological disease with normal or elevated CSF glucose concentrations. This observational cohort study used CSF and plasma analyses, as well as clinical data, from 30 participants of the Anaesthetic Biobank of Cerebrospinal Fluid study. Biomaterial was collected from adult patients scheduled for elective surgery under spinal anaesthesia. CSF polyol concentrations were measured by GC/flame ionisation detector in ten patients with normal CSF glucose levels (group 1), ten patients with elevated CSF glucose levels (group 2) and ten patients with elevated CSF glucose levels and type 2 diabetes (group 3). We compared the concentrations of plasma glucose, CSF glucose, sorbitol and fructose, and CSF polyol/glucose ratios between the three groups, and determined the correlation between plasma glucose levels and CSF glucose, sorbitol and fructose levels. Groups 2 and 3 had significantly higher CSF fructose levels compared with group 1 (p=0.036 and p<0.001, respectively). Group 3 showed significant differences compared with groups 1 and 2 for CSF sorbitol (p<0.001 and 0.036, respectively). Moreover, patients with diabetes had a significantly higher CSF sorbitol/glucose ratio compared with patients without diabetes. There was a strong positive correlation between plasma glucose and CSF glucose, sorbitol and fructose. Finally, age, sex, CSF/plasma albumin ratio and preoperative cognitive function scores were significantly correlated with plasma glucose and CSF glucose, sorbitol and fructose levels. Hyperglycaemia causes a proportional increase in polyol concentrations in CSF of patients without major neurological disease. Furthermore, this study provides the first indication of upregulation of the cerebral polyol pathway in patients with diabetes without evident neurological abnormalities.
Identifiants
pubmed: 35380232
doi: 10.1007/s00125-022-05693-7
pii: 10.1007/s00125-022-05693-7
pmc: PMC9174140
doi:
Substances chimiques
Blood Glucose
0
Polymers
0
polyol
0
Fructose
30237-26-4
Sorbitol
506T60A25R
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1098-1107Informations de copyright
© 2022. The Author(s).
Références
Proc Natl Acad Sci U S A. 1983 Feb;80(4):901-5
pubmed: 6405381
Kidney Int Suppl. 2000 Sep;77:S3-12
pubmed: 10997684
Acta Neurol Scand. 1977 Aug;56(2):104-10
pubmed: 899714
PLoS One. 2015 Jun 02;10(6):e0128582
pubmed: 26035307
Ann Surg. 2011 Apr;253(4):739-44
pubmed: 21475014
Clin Chim Acta. 1986 Jun 30;157(3):277-93
pubmed: 3731489
Trends Endocrinol Metab. 2017 Feb;28(2):88-103
pubmed: 27871675
JCI Insight. 2017 Feb 23;2(4):e90508
pubmed: 28239653
Pediatr Diabetes. 2008 Dec;9(6):531-9
pubmed: 19067891
Diabetes Care. 2014 Feb;37(2):332-40
pubmed: 24319123
Ann Transl Med. 2021 Mar;9(6):455
pubmed: 33850852
Trends Neurosci. 2013 Oct;36(10):587-97
pubmed: 23968694
Diabetologia. 1999 Jul;42(7):773-88
pubmed: 10440118
Biochem Biophys Res Commun. 2020 Jan 29;522(1):220-225
pubmed: 31759626
Int Rev Neurobiol. 2002;50:325-92
pubmed: 12198816
Minerva Anestesiol. 2015 Sep;81(9):951-9
pubmed: 25592489
J Intern Med. 2020 Mar;287(3):252-262
pubmed: 31621967
Nucl Med Biol. 2011 May;38(4):461-75
pubmed: 21531283
J Chromatogr. 1989 Dec 29;497:39-48
pubmed: 2625478
Clin Chim Acta. 1973 Mar 30;44(3):437-42
pubmed: 4694485
Neurology. 2009 Dec 1;73(22):1914-22
pubmed: 19949037
Bipolar Disord. 2008 Nov;10(7):753-64
pubmed: 19032707
J Affect Disord. 2005 Apr;85(3):341-50
pubmed: 15780705
Diabetes Res Clin Pract. 1989 Aug 1;7(2):137-9
pubmed: 2776653
J Cereb Blood Flow Metab. 2007 Nov;27(11):1766-91
pubmed: 17579656
Brain Res. 2017 Feb 15;1657:312-322
pubmed: 28034722
J Diabetes Sci Technol. 2015 Jul 21;10(1):145-50
pubmed: 26199042
Mayo Clin Proc. 2003 Dec;78(12):1471-8
pubmed: 14661676
Nature. 2001 Dec 13;414(6865):813-20
pubmed: 11742414
N Engl J Med. 1987 Mar 5;316(10):599-606
pubmed: 3027558
Biomed Pharmacother. 2018 Nov;107:306-328
pubmed: 30098549
Acta Neurol Scand. 1977 Aug;56(2):111-6
pubmed: 899715
N Engl J Med. 1990 Apr 5;322(14):978-83
pubmed: 2179725